A Feasibility Study of Sequential Hepatic Internal Radiation and Systemic Ipilimumab and Nivolumab in Patients With Uveal Melanoma Metastatic to Liver.

Study Title
A Feasibility Study of Sequential Hepatic Internal Radiation and Systemic Ipilimumab and Nivolumab in Patients With Uveal Melanoma Metastatic to Liver.
Sponsor Name
David Minor, MD
NCT Number
NCT02913417
IDE Number
G150186
CMS Approval Date
2016-12-05
Clinical Trial Link
Category
B
Website